This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
Nektar Therapeutics Inc
NKTR : NASDAQ : Health Care
$15.69 0.08 | 0.48%
Today's Range: 15.44 - 15.96
Avg. Daily Volume: 1,316,300
12/19/14 - 4:00 PM ET

PEER GROUP: Pharmaceuticals

Ticker Company Name Recent
Net Sales
Net Income
NKTR NEKTAR THERAPEUTICS 15.60 2003.68 n/m 212.30 52.82
TARO TARO PHARMACEUTICL INDS LTD 143.44 6143.82 15.73 781.84 10.22
AKRX AKORN INC 40.86 4405.97 215.05 459.06 50.86
PCRX PACIRA PHARMACEUTICALS INC 93.23 3361.50 n/m 169.44 171.38
AVNR AVANIR PHARMACEUTICALS INC 16.97 3288.09 n/m 103.98 54.62
IPXL IMPAX LABORATORIES INC 31.90 2272.81 47.61 565.58 2.49
PBH PRESTIGE BRANDS HOLDINGS 33.88 1767.62 34.22 617.44 -1.09
AUXL AUXILIUM PHARMA INC 33.84 1726.58 n/m 407.05 -9.00
MDCO MEDICINES CO 25.58 1673.44 n/m 718.41 8.46
THRX THERAVANCE INC 13.76 1587.48 n/m 2.80 -68.38
LCI LANNETT CO INC 44.04 1574.78 16.49 321.33 98.85
The peer group comparison is based on Major Pharmaceuticals companies of comparable size.

Price Earnings Comparison

NKTR Ind Avg S&P 500
n/m 32.72 19.74

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs